...
首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >Evaluation of indoor prescriptions of depression in psychiatry department of a tertiary care hospital in North India
【24h】

Evaluation of indoor prescriptions of depression in psychiatry department of a tertiary care hospital in North India

机译:印度北部一家三级医院的精神病科对抑郁症室内处方的评估

获取原文
           

摘要

Background: Depression is one of most common psychiatric illnesses affecting the human population and poses significant economic burden to society. Prescription for depression usually involves multiple medications sometime irrationally prescribed. Methods: Present study involved evaluation of 65 indoor prescriptions of patients diagnosed with depression from Psychiatry Department in a tertiary care hospital. The prescriptions were evaluated on basis of WHO Core Indicators for writing a good prescription. The demographic characteristics of the patient population were studied. Number of drugs prescribed per prescription and the average number per prescription were calculated to assess polypharmacy. The cost involved in treatment using latest market data from drug information source and the rationality of prescriptions were also evaluated. Results: 80% of the prescriptions were not in accordance with the WHO Core Indicators. An average of 2.415±1.102 medications were prescribed per prescription indicating polypharmacy. Insignificant difference was observed in cost per prescription per month of medicines when compared with lowest priced products available in market. Conclusions: Polypharmacy was found in most prescriptions and monotherapy was instituted in five prescriptions only, with clonazepam as the most prescribed antidepressant drug. Majority of prescriptions did not conform to WHO core indicators for prescription writing.
机译:背景:抑郁症是影响人口的最常见的精神疾病之一,给社会带来了巨大的经济负担。抑郁症处方通常涉及多种药物,有时不合理地处方。方法:本研究涉及对三级医院精神病科诊断为抑郁症患者的65份室内处方进行评估。根据WHO核心指标对处方进行了评估,以制定出良好的处方。研究了患者人群的人口统计学特征。计算每个处方开出的药物数量和每个处方开出的平均数量,以评估多元药房。还评估了使用药物信息来源的最新市场数据进行治疗所涉及的费用以及处方的合理性。结果:80%的处方不符合WHO的核心指标。每个处方均标明平均有2.415±1.102种药物,表明有多种药物。与市场上价格最低的产品相比,每月每个处方药的成本差异不明显。结论:大多数处方药中都存在多药治疗,只有五个处方药才采用单一疗法,而氯硝西am是处方药最多的抗抑郁药。多数处方不符合世卫组织处方核心指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号